NCT03458117: T-VEC in Non-melanoma Skin Cancer
- State
- Completed
- Phase
- Phase 1
- People
- 26 taking part
- Started
- 19 Apr 2018
- Primary completion
- 4 Feb 2022
- Arms
- Talimogene Laherparepvec (T-VEC)
- Results
- None posted
- 8 Mar 2018: Trial registered
- 19 Apr 2018: Trial started
- 15 Mar 2022: Trial completed